With cancer rising in women under 40, there's concern about the causes — and the effects. Get the latest news and impactful ...

Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced three major milestones: ...

Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally ...

It's called "Stargate," and it's one of the new Trump administration's most ambitious projects ever: lifting the restrictions ...

Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, today announced Dr. Pam Garzone, Chief Development Officer of Anixa, will be ...

Philadelphia-based Penn Medicine's Abramson Cancer Center saved its cancer patients more than 60 minutes per visit when text messaging was offered as an alternative to in-person immunotherapy ...

Breast cancer is the second leading malignant disease in females worldwide. Over decades of research, breast cancer classification by molecular subtypes has ...

The rapid pace of innovation has made us both accept and expect continuous incremental improvements in our daily life, ranging from better appliances to lighter and more advanced phones. Progressive ...

POSB Bank has unveiled a new campaign showcasing how a good money habit can go a long way. Central to the campaign is a ...

The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$7.27 billion in 2024 and an impressive US$11.01 billion by 2030. The ...

Riverain's CEO discusses expanding AI applications in medical imaging—from chest scans to the abdomen and beyond—and the ...